The WHO is considering emergency use of the Pfizer vaccine

The World Health Organization (WHO) said it had received information from Pfizer and Bioentech about the corona vaccine. They are reviewing the information available for possible enrollment in the emergency use of this vaccine.

The World Health Organization (WHO) said in a statement on Wednesday. Yesterday, the United Kingdom approved the use of coronavirus (Covid-19) vaccine, a joint venture between Pfizer and Bioentech. They are the first country in the world to approve the use of this vaccine.

The Medicines and Healthcare Products Regulatory Agency (MHRA), a UK drug regulator, says the Pfizer-Bioentech coronary vaccine is safe for the human body. The vaccination will start next week.

The UK has already ordered 40 million doses of Pfizer-Bioentech vaccine.
Pfizer, a US pharmaceutical company, and Bioentech, a German company, claim that their corona vaccine is 95 percent effective.

It is already known that the vaccine should be stored at a temperature of minus 60 degrees Celsius.The World Health Organization (WHO) said in a statement to Reuters yesterday that it was discussing the possibility of getting some information from the MHRA assessment.Which can expedite the coronary vaccine emergency use enrollment.

Mike Ryan, the World Health Organization's top emergency specialist, welcomed the news that Pfizer-Bioentech had approved the use of the corona vaccine in the United Kingdom. He says ‘We shouldn’t stop. We need three or four more vaccines. "

"We need to increase production," Mike Ryan said of the corona vaccine at a social media event. We have to reduce the price. '